Goldstein, Michael H <br/><br/>
Multicenter Study of a Novel Topical Interleukin-1 Receptor Inhibitor, Isunakinra, in Subjects With Moderate to Severe Dry Eye Disease.  [electronic resource] 

 -  Eye & contact lens  Sep 2017 
 - 287-296 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1542-233X 
<br/><br/><label>Standard No.: </label>10.1097/ICL.0000000000000276  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Double-Blind Method<br/>Female<br/>Fluorophotometry<br/>Humans<br/>Keratoconjunctivitis Sicca--diagnosis<br/>Male<br/>Middle Aged<br/>Ophthalmic Solutions<br/>Prospective Studies<br/>Proteins--adverse effects<br/>Receptors, Interleukin-1--antagonists & inhibitors<br/>Tears--physiology